Molecular Mechanisms of Angiogenesis From Ontogenesis to Oncogenesis /
Angiogenesis is a multi-stage process that drives the generation of new blood and lymphatic vessels from pre-existing ones. It is highly active during embryogenesis, largely inactive during adulthood but reactivated during wound healing and under a number of pathological conditions including cancer...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Paris :
Springer Paris : Imprint: Springer,
2014.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Emergence of Endothelial Cells During Vascular Development
- Lymphatic Vascular Morphogenesis
- Finding New Partnerships; The Function of Individual Extracellular Receptor Domains in Angiogenic Signalling by VEGF Receptors
- Wnt/ Frizzled Signaling in the Vasculature
- BMP9, BMP10 And ALK1: An Emerging Vascular Signaling Pathway With Therapeutic Applications
- Apeling Signaling in Retinal Angiogenesis
- Emerging Role of the Two Related Basic Helix-Loop-Helix Proteins
- TAL1 and LYL1 In Angiogenesis
- Hypoxia and Extracellular Matrix Remodeling
- Sphingosine-1-Phosphate in Hypoxic Signaling
- Reciprocal Crosstalk Between Angiogenesis and Metabolism
- Endothelial Progenitor Cells and Cardiovascular Ischemic Diseases: Characterization, Functions and Potential Clinical Applications as Biomarker and Therapeutic Tools
- Endothelial Cell Reactions to Oxygen: Implications For Cancer
- Tumor Angiogenesis and Lymphangiogenesis: Microenvironmental Soil For Tumor Progression And Metastatic Dissemination
- Angiogenesis And Invasion in Malignant Glioma: Friends or Foes?
- Role of Endothelial Cells in Tumor Escape From Immunity
- Tumor High-Endothelial Venules and Lymphocyte Trafficking
- Post-Transcriptional Regulation of Angiogenesis Through AU-Rich Mrna Degradation: Potential Application in Cancer Therapy
- Antiangiogenic Drugs in Cancer Therapy, Effect on Advanced Renal Cell Carcinoma
- Anti-Angiogenic Therapies in Colorectal Cancer
- Resistance to Anti-Angiogenic Treatments via Up-Regulation of Substitution Pathways
- VEGF-A Splice Variants: Do They Play a Role in Tumor Responses to Anti-Angiogenic Therapies?
- Progenitor Endothelial Cells as Biomarkers of Anti-Vascular Agents
- Soluble Vascular Endothelial (VE)-Cadherin : Toward a Marker of Endotelial Dysfunction
- The Prognostic and Predictive Value of VEGF Across Various Tumor Types.
